337 related articles for article (PubMed ID: 12952927)
81. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia.
Habra MA; Jimenez C; Huang SC; Cote GJ; Murphy WA; Gagel RF; Hoff AO
Endocr Pract; 2008 Dec; 14(9):1108-14. PubMed ID: 19158050
[TBL] [Abstract][Full Text] [Related]
82. [Pathogenesis of hypophosphatemia].
Takeuchi Y
Clin Calcium; 2016 Feb; 26(2):199-205. PubMed ID: 26813499
[TBL] [Abstract][Full Text] [Related]
83. Review and update: oncogenic osteomalacia-rickets.
Weidner N
Ultrastruct Pathol; 1991; 15(4-5):317-33. PubMed ID: 1755097
[TBL] [Abstract][Full Text] [Related]
84. Increase in phosphaturia by inhibition of renal sodium-dependent phosphate cotransporter NPT2a.
Drueke TB
Kidney Int; 2021 Mar; 99(3):533-536. PubMed ID: 33069763
[No Abstract] [Full Text] [Related]
85. [Phosphatonins: novel insights and clinical perspectives].
Mossetti G; Rendina D; De Filippo G; Zampa G; Strazzullo P
G Ital Nefrol; 2009; 26(2):171-80. PubMed ID: 19382073
[TBL] [Abstract][Full Text] [Related]
86. Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production.
Saito H; Kusano K; Kinosaki M; Ito H; Hirata M; Segawa H; Miyamoto K; Fukushima N
J Biol Chem; 2003 Jan; 278(4):2206-11. PubMed ID: 12419819
[TBL] [Abstract][Full Text] [Related]
87. Master genes for bone growth, 1,25-dihydroxyvitamin D3 synthesis, and renal conservation of phosphate and calcium.
Silver J; Drüeke TB
Curr Opin Nephrol Hypertens; 1998 Jul; 7(4):359-61. PubMed ID: 9690032
[No Abstract] [Full Text] [Related]
88. Matrix extracellular phosphoglycoprotein inhibits phosphate transport.
Marks J; Churchill LJ; Debnam ES; Unwin RJ
J Am Soc Nephrol; 2008 Dec; 19(12):2313-20. PubMed ID: 19005008
[TBL] [Abstract][Full Text] [Related]
89. Phosphatonins: a new class of phosphate-regulating proteins.
Schiavi SC; Moe OW
Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):423-30. PubMed ID: 12105393
[TBL] [Abstract][Full Text] [Related]
90. The role of vitamin D metabolites in the osteomalacia of renal disease.
Kanis JA; Brown CB; Cameron EC; Cundy T; Platts MM; Paterson M; Russell RG
Curr Med Res Opin; 1981; 7(5):294-315. PubMed ID: 7014108
[TBL] [Abstract][Full Text] [Related]
91. Effect of bromotetramisole on renal phosphate excretion.
Onsgard-Meyer M; McCoy AL; Knox FG
Proc Soc Exp Biol Med; 1996 Nov; 213(2):193-5. PubMed ID: 8931664
[TBL] [Abstract][Full Text] [Related]
92. NPT2a--the key to phosphate homeostasis.
Kronenberg HM
N Engl J Med; 2002 Sep; 347(13):1022-4. PubMed ID: 12324560
[No Abstract] [Full Text] [Related]
93. Regulation of secreted Frizzled-related protein-1 by heparin.
Zhong X; Desilva T; Lin L; Bodine P; Bhat RA; Presman E; Pocas J; Stahl M; Kriz R
J Biol Chem; 2007 Jul; 282(28):20523-33. PubMed ID: 17500071
[TBL] [Abstract][Full Text] [Related]
94. Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy.
Sato K; Shiraki M
Endocr J; 1998 Aug; 45(4):431-9. PubMed ID: 9881891
[TBL] [Abstract][Full Text] [Related]
95. Expression pattern of mouse sFRP-1 and mWnt-8 gene during heart morphogenesis.
Jaspard B; Couffinhal T; Dufourcq P; Moreau C; Duplàa C
Mech Dev; 2000 Feb; 90(2):263-7. PubMed ID: 10640709
[TBL] [Abstract][Full Text] [Related]
96. Wnt receptors and Wnt inhibitors are expressed in gradients in the developing telencephalon.
Kim AS; Lowenstein DH; Pleasure SJ
Mech Dev; 2001 May; 103(1-2):167-72. PubMed ID: 11335128
[TBL] [Abstract][Full Text] [Related]
97. Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature.
Bishay RH; Ganda K; Seibel MJ
Ther Adv Endocrinol Metab; 2017 Jan; 8(1-2):14-19. PubMed ID: 28203361
[TBL] [Abstract][Full Text] [Related]
98. Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia.
Thakare SB; Jamale TE; Memon SS
Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101839. PubMed ID: 38007379
[TBL] [Abstract][Full Text] [Related]
99. The phosphatonins and the regulation of phosphate homeostasis.
Kumar R
Ann Endocrinol (Paris); 2006 Apr; 67(2):142-6. PubMed ID: 16639365
[No Abstract] [Full Text] [Related]
100. Is FGF23 the long sought after phosphaturic factor phosphatonin?
Silve C; Beck L
Nephrol Dial Transplant; 2002 Jun; 17(6):958-61. PubMed ID: 12032180
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
